197 related articles for article (PubMed ID: 8155656)
1. Evidence for the interaction of valine-10 in cystatin C with the S2 subsite of cathepsin B.
Lindahl P; Ripoll D; Abrahamson M; Mort JS; Storer AC
Biochemistry; 1994 Apr; 33(14):4384-92. PubMed ID: 8155656
[TBL] [Abstract][Full Text] [Related]
2. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
Pavlova A; Björk I
Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
[TBL] [Abstract][Full Text] [Related]
3. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.
Mason RW; Sol-Church K; Abrahamson M
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):833-8. PubMed ID: 9480898
[TBL] [Abstract][Full Text] [Related]
4. Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition.
Hall A; Dalbøge H; Grubb A; Abrahamson M
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):123-9. PubMed ID: 8471031
[TBL] [Abstract][Full Text] [Related]
5. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for different inhibitory specificities of human cystatins C and D.
Hall A; Ekiel I; Mason RW; Kasprzykowski F; Grubb A; Abrahamson M
Biochemistry; 1998 Mar; 37(12):4071-9. PubMed ID: 9521728
[TBL] [Abstract][Full Text] [Related]
7. Probing the functional role of the N-terminal region of cystatins by equilibrium and kinetic studies of the binding of Gly-11 variants of recombinant human cystatin C to target proteinases.
Björk I; Brieditis I; Abrahamson M
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):513-8. PubMed ID: 7887904
[TBL] [Abstract][Full Text] [Related]
8. Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity.
Brömme D; Bonneau PR; Lachance P; Storer AC
J Biol Chem; 1994 Dec; 269(48):30238-42. PubMed ID: 7982933
[TBL] [Abstract][Full Text] [Related]
9. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.
Pol E; Björk I
Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663
[TBL] [Abstract][Full Text] [Related]
10. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
Pol E; Björk I
Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
[TBL] [Abstract][Full Text] [Related]
11. Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes.
Björk I; Pol E; Raub-Segall E; Abrahamson M; Rowan AD; Mort JS
Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):219-25. PubMed ID: 8166644
[TBL] [Abstract][Full Text] [Related]
12. The importance of the second hairpin loop of cystatin C for proteinase binding. Characterization of the interaction of Trp-106 variants of the inhibitor with cysteine proteinases.
Björk I; Brieditis I; Raub-Segall E; Pol E; Håkansson K; Abrahamson M
Biochemistry; 1996 Aug; 35(33):10720-6. PubMed ID: 8718861
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: influence of the peptidyl chain length.
Hall A; Abrahamson M; Grubb A; Trojnar J; Kania P; Kasprzykowska R; Kasprzykowski F
J Enzyme Inhib; 1992; 6(2):113-23. PubMed ID: 1284427
[TBL] [Abstract][Full Text] [Related]
14. Contributions of individual residues in the N-terminal region of cystatin B (stefin B) to inhibition of cysteine proteinases.
Pol E; Björk I
Biochim Biophys Acta; 2003 Jan; 1645(1):105-12. PubMed ID: 12535617
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases.
Hall A; Håkansson K; Mason RW; Grubb A; Abrahamson M
J Biol Chem; 1995 Mar; 270(10):5115-21. PubMed ID: 7890620
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site.
Alvarez-Fernandez M; Barrett AJ; Gerhartz B; Dando PM; Ni J; Abrahamson M
J Biol Chem; 1999 Jul; 274(27):19195-203. PubMed ID: 10383426
[TBL] [Abstract][Full Text] [Related]
17. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L.
Estrada S; Pavlova A; Björk I
Biochemistry; 1999 Jun; 38(22):7339-45. PubMed ID: 10353845
[TBL] [Abstract][Full Text] [Related]
18. The affinity and kinetics of inhibition of cysteine proteinases by intact recombinant bovine cystatin C.
Olsson SL; Ek B; Björk I
Biochim Biophys Acta; 1999 Jun; 1432(1):73-81. PubMed ID: 10366730
[TBL] [Abstract][Full Text] [Related]
19. Quail cystatin: isolation and characterisation of a new member of the cystatin family and its hypothetical interaction with cathepsin B.
Gerhartz B; Engh RA; Mentele R; Eckerskorn C; Torquato R; Wittmann J; Kolb HJ; Machleidt W; Fritz H; Auerswald EA
FEBS Lett; 1997 Aug; 412(3):551-8. PubMed ID: 9276465
[TBL] [Abstract][Full Text] [Related]
20. Hybrids of chicken cystatin with human kininogen domain 2 sequences exhibit novel inhibition of calpain, improved inhibition of actinidin and impaired inhibition of papain, cathepsin L and cathepsin B.
Auerswald EA; Nägler DK; Gross S; Assfalg-Machleidt I; Stubbs MT; Eckerskorn C; Machleidt W; Fritz H
Eur J Biochem; 1996 Feb; 235(3):534-42. PubMed ID: 8654398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
